| ROOM 15 | |||||
|
WS.IX HEALTH INNOVATION in ACTION: 18 September |
|||||
| Co-organized with: | |||||
 |
 |
||||
|
WORKSHOP COMMITTEE |
|||||
|
A journey through the latest advances in nanomedicine, targeted drug delivery, and innovative diagnostics, alongside a discussion on how evidence-based policies can support their integration into healthcare. The event connects cutting-edge research with practical applications, highlighting the role of technology, collaboration, and policy in shaping a smarter, more effective, and patient-centered health system for the future. |
|||||
| 18 September | ||||||||
| 10:50 - 11:30 | ||||||||
| Insight Parallel Sessions (IS.II) | ||||||||
| Chair: Marzia BEDONI, Don Gnocchi Foundation | ||||||||
| Nanomedicine is gaining strategic relevance in Europe’s innovation landscape, offering transformative potential for healthcare. Integrating advanced solutions requires coordinated efforts across research, clinical practice, industry, and policy. A structured approach to collaboration will be outlined, emphasizing the value of cross-sector engagement. Dialogue among actors at different stages of technological maturity is key to unlocking new pathways. Breaking cultural and organizational barriers enables more inclusive and effective innovation. Real-world examples will illustrate how diverse ecosystems can accelerate adoption. The session promotes a shift from siloed development to shared impact. Attendees will explore tools to navigate complexity and co-design future directions. The focus is on sustainable, patient-centred transformation. A call to rethink innovation as a collective, dynamic process. | ||||||||
| WS.IX.1 IS.II.E |
Alexandre CECCALDI - CV ETPN Looking Ahead: Nanomedicine in the European R&I Landscape |
 |
||||||
| Furio GRAMATICA - CV Don Gnocchi Foundation In dialogue with all the actors of the health technology ecosystem: the role of evidence-based policies |
 |
|||||||
| 11:30 - 13:00 Health Innovation in Action: Nanomedicine, Diagnostics and Smarter Policies 1/2 WS.IX.2 - TT.VI.E |
||||||||
|
Chair: in definition
|
||||||||
|
|
||||||||
| WS.IX.2.1 TT.VI.E.1 |
Gabriella COSTABILE - CV University of Naples, Federico II Targeting the CD105/Endoglin Pathway in Pulmonary Fibrosis via Inhalable siRNA Delivered by pH-Responsive Lipid@PLGA hybrid Nanoparticles |
 |
||||||
| WS.IX.2.2 TT.VI.E.2 |
Ivana D'ANGELO - CV University of Campania, Luigi Vanvitelli Inhalable nanoparticles for antimicrobial peptide delivery in lung infections |
 |
||||||
| WS.IX.2.3 TT.VI.E.3 |
Maria Gioia FABIANO - CV Sapienza University of Rome Exploring Safety-by-Design: physicochemical properties and ecotoxicological evaluation of thyme oil-based nanocarriers |
 |
||||||
| WS.IX.2.4 TT.VI.E.4 |
Ilaria OTTONELLI - CV University of Modena and Reggio Emilia Gene Delivery Nanomedicine Platform |
 |
||||||
| WS.IX.2.5 TT.VI.E.5 |
Hiba NATSHEH - CV An-Najah National University Enhanced transdermal delivery and therapeutic effect of caryophyllene oxide via topical application in a transethosomal system |
 |
||||||
| 14:00 - 15:30 Health Innovation in Action: Nanomedicine, Diagnostics and Smarter Policies 2/2 WS.IX.3 - TT.VII.E |
||||||||
| Chair: in definition | ||||||||
|
|
||||||||
| WS.IX.3.1 TT.VII.E.1 |
Annalisa RADEGHIERI - CV University of Brescia Methodological Advances to Study the Extracellular vesicle Biomolecular Corona for Diagnostics and Therapeutics |
 |
||||||
| WS.IX.3.2 TT.VII.E.2 |
Carlo MORASSO - CV Maugeri Foundation Next-Gen EV Liquid Biopsy: MSP-Enhanced SiMoA Detects HER2 in Metastatic Breast Cancer Plasma |
 |
||||||
| WS.IX.3.3 TT.VII.E.3 |
Luana FORLEO - CV Don Gnocchi Foundation SERS analysis of saliva by portable Raman for diagnosis and management of patients with Chronic Obstructive Pulmonary disease |
 |
||||||
| WS.IX.3.4 TT.VII.E.4 |
Laura VUCICIC University of Tor Vergata Boosting GSA-10 Solubility: Deep Eutectic Solvents as a Next-Generation Drug Delivery Platform |
 |
||||||
 |
Back to Overview | Go to Plan 18 September |  |